Results 181 to 190 of about 2,495,332 (299)

Authors’ Response to “Comment on ‘SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis’”

Journal of Translational Medicine
Bita Rostami-Afshari, Wesam Elremaly, Anita Franco, Alain Moreau   +3 more
doaj   +1 more source

Spatial transcriptomics: challenges and future directions in musculoskeletal diseases. [PDF]

Curr Opin Rheumatol
Delos Santos K, Rockel JS, Kapoor M.
europepmc   +1 more source

Anti‐Carbamylated Protein Antibodies Stabilize Carbamylated Histone H3 to Promote Synovial Activation and Neutrophil Extracellular Trap‐Mediated Bone Loss in Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Carbamylation, a nonenzymatic post‐translational modification, contributes to rheumatoid arthritis (RA) pathogenesis. Anti‐carbamylated protein antibodies (anti‐CarP) occur in around 50% of patients with RA and associate with greater joint damage. Neutrophil extracellular traps (NETs) are a major source of carbamylated autoantigens. We sought
Shuichiro Nakabo, Norio Hanata, Eduardo Patino‐Martinez, Ronald Holewinski, Ana Barrera‐Vargas, Javier Merayo‐Chalico, Scott A. Coonrod, David A. Fox, Mariana J. Kaplan, Carmelo Carmona‐Rivera   +9 more
wiley   +1 more source

Correction: World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025). [PDF]

Aging Clin Exp Res
europepmc   +2 more sources

GLP-1 and GIP: Magic bullet for musculoskeletal diseases? [PDF]

J Adv Res
Fang Q, Li G, Liu P, Ding P, Gao Y.
europepmc   +1 more source

Increased absence due to sickness among employees with fibromyalgia [PDF]

, 2007
Vahtera, Jussi, Kivimäki, Mika, Virtanen, M, Pentti, Jaana, Leino-Arjas, P, Keltikangas-Jarvinen, L, Virtanen, Marianna, Pentti, J, Vahtera, J, Elovainio, M, Kaila-Kangas, Leena, Puttonen, S, Puttonen, Sampsa, Kivimaki, M, Leino-Arjas, Päivi, Elovainio, Marko, Keltikangas-Järvinen, Liisa, Kaila-Kangas, L   +17 more
core  

Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration

Arthritis &Rheumatology, EarlyView.
Objective To develop, externally validate, and simplify a machine learning model to predict remission between 6 and 24 months in patients with rheumatoid arthritis (RA) initiating tumor necrosis factor inhibitors, JAK inhibitors, interleukin‐6 inhibitors, abatacept, or rituximab using data from 11 international registries in the JAK‐pot collaboration ...
Zubeyir Salis, Denis Mongin, Denis Choquette, Louis Coupal, Catalin Codreanu, Florenzo Iannone, Roberto Caporali, Tore K. Kvien, Sella Provan, Ruth Fritsch‐Stork, Dan Nordström, Nina Trokovic, Karel Pavelka, Jakub Závada, Ana Rodrigues, Ziga Rotar, Prodromos Sidiropoulos, Irini Flouri, Céline Lamacchia, Michele Iudici, Delphine Courvoisier, Kim Lauper, Axel Finckh   +22 more
wiley   +1 more source

Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases. [PDF]

Gut Microbes
Yang W, Hao C, Wang N, Xie J, Zhou B, Yang Z, Zheng A, Wei J, Li C, Xie C, Li H, Lei G, Zeng C.   +12 more
europepmc   +1 more source

Nerve Growth Factor is Sufficient to Cause Multiple Osteoarthritis‐Relevant Pathologic Features in Naïve Murine Knee Joints

Arthritis &Rheumatology, EarlyView.
Objective Nerve growth factor (NGF), a key mediator of pain, is increased in osteoarthritic (OA) joints. Antibodies against NGF show analgesic effects in painful knee OA, but clinical development was stopped because of side effects in the joints. Knowledge about the biologic effects of NGF on joint tissues is limited. Therefore, we explored the effects
Alia M. Obeidat, Michael D. Newton, Jun Li, Baofeng Hu, Shingo Ishihara, Lindsey Lammlin, Lucas M. Junginger, Easton C. Farrell, Lai Wang, Frank C. Ko, Richard J. Miller, Carla R. Scanzello, Tristan Maerz, Rachel E. Miller, Anne‐Marie Malfait   +14 more
wiley   +1 more source

Patient awareness and perception of cardiovascular risk in rheumatic and musculoskeletal diseases: results from an international survey. [PDF]

EULAR Rheumatol Open
Alunno A, Rodríguez-Carrio J, van Leuven S, Ritschl V, Schmolik V, Böhm P, Marchiori F, Schreiber K, Husum D, Stamm T, Szucs G, Atzeni F, Szekanecz Z, Nurmohamed M, EULAR Cardiovascular in inflammatory arthritis (CVIIA) Study Group members.   +14 more
europepmc   +1 more source